India’s CRO industry’s evolution over the past decade has been phenomenal. From a strategic outsourcing service leveraged for its cost-efficiency, the industry has turned into an essential innovation partner for brands, both established and emerging. Tightening regulatory norms coupled with rising trial complexity, increasing R&D costs, stricter regulations, and patient-centric approaches are behind the sector’s shift.
Decentralized and hybrid trial models, emerging digital technologies, and implementation of real-world evidence are fueling its growth. But, challenges like patient recruitment and retention to regulatory complexities, high trivial costs, and unreliable data, curb the sector’s potential too.
Demand for scientific rigor and collaborative operations is high, which is where PRORELIX RESEARCH emerges as the perfect partner. Blending scientific expertise, regulatory insight, and operational agility, PRORELIX RESEARCH delivers global-quality services with local expertise with faster, reliable outcomes.
With flexibility and collaboration, the company embodies agility and personalized attention for every client across its innovative solutions. Delivering efficient, compliant, and timely solutions across hybrid trial models, data-driven recruitment, and patient-centric strategies, the firm enables companies to accelerate product development confidently.
Thriving On Trust & Technology
Conquering the competitive CRO landscape with its cutting-edge solutions, PRORELIX RESEARCH has established trust in the market. Aligned with the core values of consistent quality, transparency, and client success, the company brings a deeply personalized approach that sets it apart. It utilizes the team’s deep scientific expertise and regulatory understanding to customize solutions as per client-specific need.
“Unlike most CROs where clients may feel like one among many, we ensure close collaboration, agility, and responsiveness at every stage. We see ourselves not just as service providers but as true partners, dedicated to accelerating development while safeguarding quality, patient safety, and regulatory compliance”, shares Niranjan Andhalkar, Director, PRORELIX RESEARCH.
PRORELIX RESEARCH's remarkable record of delivering compliant, timely, and cost-effective solutions across global and emerging markets reinforces its credibility, while implementation of advanced technologies enhances outcomes.
Leveraging decentralized and hybrid clinical trial technologies, the company assures efficiency and precision across its clinical research operations. The transformative tools are strategically utilized to facilitate smarter protocol designs, faster patient recruitment through predictive analytics, and early identification of potential safety or efficacy trends.
But it’s not just service provision where PRORELIX RESEARCH shines. Committed to client success, the company values operational excellence, which it achieves with its bold quality assurance framework. The framework integrates continuous improvement, proactive risk management, and strict adherence to global regulatory standards such as ICH-GCP, FDA, and EMA guidelines. Dedicated teams for performing regular audits, CAPA reviews, and internal training ensures project success.
PRORELIX RESEARCH's quality assurance measures leverage automation, which supports consistency and efficiency across data validation, document control, and monitoring workflows. With this implementation, the firm effectively reduces human error, thereby quickening turnaround times. At PRORELIX RESEARCH, compliance, technology, and a culture of accountability go hand-in-hand, driving success across all clinical operations.
The Go-to, All-in-One CRO
PRORELIX RESEARCH boasts a broad portfolio of services.
The go-to CRO for diverse solutions, the firm’s expertise spans clinical trial management, pharmacovigilance, regulatory affairs, medical writing, data management, and biostatistics. For companies in this domain, PRORELIX acts as an end-to-end partner, simplifying product development, accelerating progress.
“Our differentiator lies in the way we deliver these services– with agility, personalized attention, and scientific excellence. Our strong regulatory expertise, global delivery capability, and patient-focused strategies enable us to manage complex projects with precision and efficiency. Clients trust us because we go beyond execution, we act as partners who align with their goals and deliver results that truly matter”, adds Niranjan Andhalkar.
Behind the CRO’s success, strength, and versatility lies a highly dynamic, multidisciplinary team comprising data experts, regulatory specialists, and project managers. Transparent and seamless team collaborations enables the firm to distinguish its solutions. Drawing from every professional’s deep domain knowledge, analytical rigor, and problem-solving capabilities, PRORELIX RESEARCH innovates customized solutions that solve specific client problems.
The cross-functional synergy is a cornerstone of PRORELIX RESEARCH's edge. It encourages streamlined operations, fostering a culture of continuous learning, technology adoption, and proactive communication. These practices enable faster decision-making, risk mitigation, and delivery of high-quality, innovative outcomes, making the company a partner of choice. PRORELIX RESEARCH doesn’t just provide services. It provides actionable insights that allow clients expedite development of products. Staying ahead of the curve, the company emphasized assessment and rapid adoption of emerging methodologies that support reliable research outcomes.
“We believe innovation is the cornerstone of clinical excellence. Our R&D investments focus on enhancing trial efficiency, data integrity, and regulatory compliance through advanced technologies and process optimization”, further adds Niranjan Andhalkar.
Journey & Future Roadmap
A revolutionary organization founded by industry experts in 2015 PRORELIX RESEARCH started its journey fueled by the powerful vision to revamp the clinical research landscape with integrity, innovation, and global excellence. Its journey of steady and strategic growth has been shaped by the visionary founder and the dedicated team working towards the shared goals of success.
From modest beginnings to transforming into a global CRO present across India and the US, PRORELIX RESEARCH has achieved tremendous milestones in the past decade. A vast site network across Europe and Southeast Asia further strengthens the company’s presence. Over this period, the firm also established diversified expertise in clinical operations, pharmacovigilance, regulatory affairs, and medical writing.
Success after success from multi-country trial management to long-term collaborations with global sponsors define the company’s journey accurately. These experiences enabled the firm to reinforce its reliability and quality-centric expertise; encouraging it to continue delivering ethically sound, innovative, and efficient clinical research solutions.
“Our vision is to be a trusted global partner advancing healthcare through scientific excellence. Driven by a passion for science and a commitment to client success, we continue to shape the future of healthcare by advancing safe, effective, and ethical clinical research”, lastly adds Niranjan Andhalkar.
Our vision is to be a trusted global partner advancing healthcare through scientific
Compelled to achieve its ambitious vision, the company’s future roadmap prioritizes sustainable growth and innovation. It has planned expansions across new geographies, strengthening partnerships with biotech and pharmaceutical companies, and investing in advanced technologies. Advanced Hybrid clinical trials and digital clinical trial management are currently being targeted for growth and expansion.
Embracing technology for all its worth, the company plans to continually refine its solutions by leveraging AI-driven insights by integrating them across data management and project management processes. With this, it aims to deliver more robust, data-backed outcomes, ultimately accelerating timelines and improving decision-making throughout the drug development cycle.
On the mission to boost operational efficiency, accelerate clinical study timelines, and ensure the highest standards of quality and compliance, PRORELIX RESEARCH plans to deepen its expertise in emerging therapeutic areas and real-world evidence studies. With these strategic objectives, it envisions a future where PRORELIX RESEARCH is the world’s leading, trusted, full-service CRO, shaping the future of clinical development.
Vast And Agile CRO Capabilities
PRORELIX RESEARCH STANDS OUT FOR THE QUALITY AND PRECISION OF ITS SOLUTIONS FOR A GLOBAL CLIENTELE.
SINCE ITS INCEPTION, THE COMPANY HAS COMPLETED OVER 150 SUCCESSFUL STUDIES IN ONCOLOGY, DERMATOLOGY, RESPIRATORY, ENDOCRINOLOGY, AUTOIMMUNE, CNS, CARDIOLOGY.
ITS RELIABLE AND ETHICAL PRACTICES HAVE EARNED THE COMPANY THE TRUST OF SPONSORS, INVESTIGATORS, AND PATIENTS AROUND THE WORLD.
WITH A PASSION TO BRING PATIENTS CLOSER TO HEALING, THE COMPANY HAS CONDUCTED TRIALS ACROSS CONTINENTS, IN RURAL SETUPS AND URBAN ICUS.
OVER THE YEARS, IT HAS ALSO TRAINED OVER 500 INVESTIGATORS FOR COMPASSIONATE EXECUTION, BECOMING AN ALL-ROUND PARTNER.
We use cookies to ensure you get the best experience on our website. Read more...
